@article{46f09c30c97546d5b9f1c2b803790d7a,
title = "Structural Analysis of Class i Lanthipeptides from Pedobacter lusitanus NL19 Reveals an Unusual Ring Pattern",
abstract = "Lanthipeptides are ribosomally synthesized and post-translationally modified peptide natural products characterized by the presence of lanthionine and methyllanthionine cross-linked amino acids formed by dehydration of Ser/Thr residues followed by conjugate addition of Cys to the resulting dehydroamino acids. Class I lanthipeptide dehydratases utilize glutamyl-tRNAGlu as a cosubstrate to glutamylate Ser/Thr followed by glutamate elimination. A vast majority of lanthipeptides identified from class I synthase systems have been from Gram-positive bacteria. Herein, we report the heterologous expression and modification in Escherichia coli of two lanthipeptides from the Gram-negative Bacteroidetes Pedobacter lusitanus NL19. These peptides are representative of a group of compounds frequently encoded in Pedobacter genomes. Structural characterization of the lanthipeptides revealed a novel ring pattern as well as an unusual ll-lanthionine stereochemical configuration and a cyclase that lacks the canonical zinc ligands found in most LanC enzymes.",
author = "Bothwell, {Ian R.} and T{\^a}nia Caetano and Raymond Sarksian and S{\'o}nia Mendo and {Van Der Donk}, {Wilfred A.}",
note = "Funding Information: This work was supported by the National Institutes of Health (GM 058822 to W.A.v.d.D. and F32 GM117765 to I.R.B.). The authors thank A. Ulanov and Z. Li from the Roy J. Carver Biotechnology Center (Metabolomics Facility) of the University of Illinois at Urbana-Champaign (UIUC) for assistance with chiral GC-MS analysis. The authors also thank L. Zhu (UIUC School of Chemical Sciences NMR Laboratory) and J. Acedo (Mount Royal University, Calgary, AB) for assistance with the collection and interpretation of NMR data. T.C. was funded by national funds (OE), through FCT in the scope of the framework contract foreseen in the numbers 4, 5, and 6 of article 23, of the Decree-Law 57/2016, of August 29, changed by Law 57/2017, of July (CEECIND/01463/2017), and a postdoctoral scholarship funded by FCT, EU, and POPH (SFRH/BPD/77900/2011). CESAM is a research unit financially supported by FCT/MCTES (UIDP/50017/2020 and UIDB/50017/2020), through national funds. A Bruker UltrafleXtreme MALDI-TOF MS instrument used for this study was purchased in part with a grant from the National Institutes of Health (S10 RR027109 A). Publisher Copyright: {\textcopyright} ",
year = "2021",
month = jun,
day = "18",
doi = "10.1021/acschembio.1c00106",
language = "English (US)",
volume = "16",
pages = "1019--1029",
journal = "ACS chemical biology",
issn = "1554-8929",
publisher = "American Chemical Society",
number = "6",
}